DIFLUOROMETHYLORNITHINE COUNTERACTS LESION-INDUCED ASTROGLIOSIS IN RAT HIPPOCAMPUS - ENHANCEMENT OF INHIBITORY EFFECT BY COMBINED TREATMENTWITH GM1 GANGLIOSIDE
W. Jeglinski et al., DIFLUOROMETHYLORNITHINE COUNTERACTS LESION-INDUCED ASTROGLIOSIS IN RAT HIPPOCAMPUS - ENHANCEMENT OF INHIBITORY EFFECT BY COMBINED TREATMENTWITH GM1 GANGLIOSIDE, Acta Neurobiologiae Experimentalis, 56(2), 1996, pp. 549-553
The effect of difluoromethylornithine (DFMO), an irreversible inhibito
r of ornithine decarboxylase (ODC), the rate limiting enzyme of polyam
ine biosynthesis, and its combined action with GM1 ganglioside, was st
udied on the GFAP content in a model of remote astrogliosis evoked in
the hippocampus by lateral fimbria transection. DFMO markedly suppress
ed hippocampal gliosis as measured by GFAP immunoblotting seven days p
ostsurgery. Combined treatment with DFMO and GM1 ganglioside - a subst
ance which alone also counteracts hippocampal gliosis, produced a stro
nger suppressive effect than DFMO. The results support the hypothesis
of a causal link between lesion induced events: polyamine biosynthesis
and astroglial reaction. Potentiation of the inhibitory effect of DFM
O by GM1 ganglioside suggests that the latter does not act through the
mechanism involving ODC suppression.